Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL7862995 | 0.93 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2APOLBCYP2C9 | |
| Ether SCHEMBL6783353 | 0.90 | MEN1 (0.31) | ALDH1A1MEN1KMT2APOLB | |
| Cyclohexane SCHEMBL7301137 | 0.90 | MEN1 (0.31) | ALDH1A1MEN1KMT2APOLB | |
| Ether SCHEMBL7679488 | 0.90 | ALDH1A1 (0.43) | ALDH1A1MEN1KMT2APOLBCYP2C9 | |
| Hexane SCHEMBL2037219 | 0.87 | TSHR (0.39) | ALDH1A1MEN1KMT2A | |
| Ether SCHEMBL11167561 | 0.85 | — | — | |
| SCHEMBL2498447 | 0.79 | — | — | |
| Ether SCHEMBL8160191 | 0.78 | ALDH1A1 (0.47) | ALDH1A1KMT2A | |
| Ether SCHEMBL21406 | 0.78 | ALDH1A1 (0.47) | ALDH1A1KMT2A | |
| Ether SCHEMBL9248046 | 0.78 | ALDH1A1 (0.47) | ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117618332-A | Minoxidil-containing preparation and process thereof | 药大制药有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-116178442-A | Preparation method of (2, 2-trifluoro-ethoxy) pentafluoro-cyclotriphosphazene | 宁德国泰华荣新材料有限公司 | 2023-05-30 | — | — | CN | claimed |
| US-11976178-B2 | Compositions with coated carbon fibers and methods for manufacturing compositions with coated carbon fibers | THE BOEING COMPANY (US) | 2024-05-07 | — | — | US | disclosed |
| CN-117618332-A | Minoxidil-containing preparation and process thereof | 药大制药有限公司 | 2024-03-01 | — | — | CN | disclosed |
| US-11696497-B2 | Organic light emitting device | LG DISPLAY CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| CN-116178442-A | Preparation method of (2, 2-trifluoro-ethoxy) pentafluoro-cyclotriphosphazene | 宁德国泰华荣新材料有限公司 | 2023-05-30 | — | — | CN | disclosed |
| US-20200203620-A1 | ORGANIC LIGHT EMITTING DEVICE | LG DISPLAY CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
| CN-110325587-A | Methacrylic resin composition and application thereof | 株式会社可乐丽 | 2019-10-11 | — | — | CN | disclosed |
| US-20190216895-A1 | BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF | LAUREN SCIENCES LLC (US) | 2019-07-18 | — | — | US | disclosed |
| EP-3476905-A1 | COMPOSITIONS WITH COATED CARBON FIBERS AND METHODS FOR MANUFACTURING COMPOSITIONS WITH COATED CARBON FIBERS | The Boeing Company (US) | 2019-05-01 | — | — | EP | disclosed |
| US-20190119469-A1 | COMPOSITIONS WITH COATED CARBON FIBERS AND METHODS FOR MANUFACTURING COMPOSITIONS WITH COATED CARBON FIBERS | THE BOEING COMPANY | 2019-04-25 | — | — | US | disclosed |
| EP-0297855-A1 | Aminocyclopentyl ethers and their preparation and pharmaceutical formulation | GLAXO GROUP LIMITED (GB) | 1989-01-04 | — | — | EP | disclosed |
| EP-0297853-A1 | Preparation of 5-biphenylmethoxy-3-hydroxy-2- piperdinylcyclopentyl-4-heptenoic acid | GLAXO GROUP LIMITED (GB) | 1989-01-04 | — | — | EP | disclosed |
| EP-0260066-A1 | Tamoxifen derivatives | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1988-03-16 | — | — | EP | disclosed |
| EP-0033255-B1 | OXIMES DERIVED FROM ERYTHROMYCIN A, THEIR PREPARATION, THEIR APPLICATION IN PHARMACEUTICALS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ROUSSEL-UCLAF (FR) | 1984-08-29 | — | — | EP | disclosed |
| US-4349545-A | Novel erythromycin a derivatives | ROUSSEL UCLAF (FR) | 1982-09-14 | — | — | US | disclosed |
| EP-0033255-A1 | Oximes derived from erythromycin A, their preparation, their application in pharmaceuticals and pharmaceutical compositions containing them | ROUSSEL-UCLAF (FR) | 1981-08-05 | — | — | EP | disclosed |
| US-4113863-A | PROSTENOIC ACID DERIVATIVES | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1978-09-12 | — | — | US | disclosed |
| US-4091226-A | Novel cyclopentenecarboxylates | ROUSSEL UCLAF (FR) | 1978-05-23 | — | — | US | disclosed |
| US-4086362-A | Prostenoic acid derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1978-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200203620-A1 | ORGANIC LIGHT EMITTING DEVICE | MAP1LC3A, MAP1LC3C, MAP1LC3B | ALDH1A1 930/4885MEN1 3195/4885KMT2A 1928/4885 |
| US-11696497-B2 | Organic light emitting device | MAP1LC3A, MAP1LC3C, MAP1LC3B | ALDH1A1 930/4885MEN1 3195/4885KMT2A 1928/4885 |
| US-20190216895-A1 | BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF | GFRA2, GFRA1, NGF | ALDH1A1 133/4885MEN1 852/4885KMT2A 4278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.